Chimeric antigen receptor T cells - Globe Thesis

Keyword [Chimeric antigen receptor T cells] Result: 61 - 79 \| Page: 4 of 4
61.	B7-H3-targeted CAR-T Cells Against Relapsed Brain Glioblastoma And Medulloblastoma
62.	Function And Molecular Mechanisms Of Epidermal Growth Factor Receptor-targeted Chimeric Antigen Receptor T Cells In Triple Negative Breast Cancer And The Combined Therapeutic Strategies
63.	Effects Of Cytokines And Oncolytic Adenovirus Loaded With Cytokine On The Enhancement Of B7H3-targeted CAR-T Cells Against Head And Neck Tumors
64.	Lipid Nanoparticles Produce Chimeric Antigen Receptor T Cells And Chimeric Antigen Receptor Macrophages In Vivo
65.	Study On The Effect And Mechanism Of Qiyin Sanliangsan In Assisting CD19 CAR-T Cells In The Treatment Of B-cell Lymphom
66.	Study On The Novel BCMA/CD38 Tandem Dual-targeting Chimeric Antigen Receptor T Cells For The Treatment Of Multiple Myelom
67.	Photosensitive ROS Liposomes Encapsulated With Dimerization Small Molecule Drugs Remotely Activate CAR-T Cell Immune Responses
68.	Antitumor Effect And Mechanism Of Chimeric Antigen Receptor T Cells Based On Nanobody Targeting FAP And Secreting CTLA-4
69.	The Study On Anti-tumor Effect And Mechanism Of A Novel Type CD105-targeted And CTLA-4-Secretiing CAR T Cells
70.	The Role Of Bi-specific CAR-T Cells Targeting B7H3 And IL13Rα2 In The Treatment Of Lung Metastasis Of Triple Negative Breast Cancer
71.	Efficacy And Safety Of Human BCMA CAR-T In The Treatment Of Relapsed And Refractory Multiple Myeloma
72.	Gilteritinib Synergizes With FLT3-NKG2D-CAR T In FLT3-mutated Acute Myeloid Leukemia And The Underlying Molecular Mechanism
73.	Establishment Of Organoids To Promote Personalized And Immunotherapeutic Research For Bladder Cancer
74.	Efficacy And Safety Study Of Bridging Allogeneic Haematopoietic Stem Cell Transplantation After CAR-T Cells Therapy For Adult Relapsed/Refractory Acute B Lymphoblastic Leukemia
75.	Efficacy And Safety Of Anti-CD19/CD22 Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphoblastic Leukemia
76.	Construction And Functional Evaluation Of Integrated SOCS5 Chimeric Antigen Receptor T(CAR-T) Cells
77.	Clinical Study Of CD19 Prime CAR T Cell For Relapsed/refractory Acute B-lymphocytic Leukemia
78.	Role Of CLL1 CAR T-cells In Children With Refractory/Relapsed Acute Myeloid Leukemia
79.	Efficacy And Safety Of CD19 Chimeric Antigen Receptor T Cells Therapy In Patients With Relapsed Acute B Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
<<First <Prev Next> Last>> Jump to